首页>
外国专利>
Use of halogenated volatile anesthetic in the manufacture of a formulation for use in the treatment of a patient having tissue that is subject to an ischemic event
Use of halogenated volatile anesthetic in the manufacture of a formulation for use in the treatment of a patient having tissue that is subject to an ischemic event
展开▼
机译:卤代挥发性麻醉剂在制备制剂中的用途,所述制剂用于治疗具有遭受缺血事件的组织的患者
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided is a method of treating a patient having a tissue that is subject to an ischemic event. The method is conducted by parenterally administering a formulation containing a halogenated volatile anesthetic in an amount effective to improve the tissue's resistance to or tolerance of the ischemic event. In preferred embodiment of the invention, the amount of the formulation administered to the patient is sub-anesthetic. The formulation can be administered prior to, concurrently with, or after the ischemic event. The method can be used, for example, for treatment of patients having myocardial or neuronal tissue that is subject to an ischemic event.
展开▼